{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Healthy+Volunteers.&page=12", "query": { "condition": "Healthy Volunteers.", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 7024, "total_pages": 703, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Healthy+Volunteers.&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Healthy+Volunteers.&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T12:07:33.295Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06435923", "title": "A Trial to Assess the Absorption, Metabolism, Excretion, and Mass Balance of [14C]-Darigabat After a Single Oral Dose in Healthy Male Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "[14C]-darigabat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cerevel Therapeutics, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 8, "start_date": "2024-05-29", "completion_date": "2024-07-03", "has_results": false, "last_update_posted_date": "2024-07-31", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06435923" }, { "nct_id": "NCT02222324", "title": "A Study to Evaluate the Effects of E2609 on QTc Interval in Healthy Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Subjects" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "E2609", "type": "DRUG" }, { "name": "Moxifloxacin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eisai Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 60, "start_date": "2014-08", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-11-03", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02222324" }, { "nct_id": "NCT05806359", "title": "A Study to Evaluate the Safety, Tolerability, and Drug Levels of Danicamtiv in Healthy Japanese and Caucasian Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Danicamtiv", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 33, "start_date": "2023-03-31", "completion_date": "2023-08-14", "has_results": false, "last_update_posted_date": "2024-05-23", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 1, "location_summary": "Anaheim, California", "locations": [ { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05806359" }, { "nct_id": "NCT05592379", "title": "Consciousness, Psilocybin, and Well-Being", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy", "Psychedelic Experiences", "Sleep" ], "interventions": [ { "name": "Psilocybin", "type": "DRUG" }, { "name": "Clonidine", "type": "DRUG" }, { "name": "Saline", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 6, "start_date": "2023-11-07", "completion_date": "2025-02-19", "has_results": false, "last_update_posted_date": "2025-05-16", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05592379" }, { "nct_id": "NCT03344510", "title": "Kinetic Anesthesia Device Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Local Anaesthetic Complication", "Pain" ], "interventions": [ { "name": "Kinetic Anesthesia Device", "type": "DEVICE" }, { "name": "Control", "type": "OTHER" } ], "intervention_types": [ "DEVICE", "OTHER" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 47, "start_date": "2017-01-23", "completion_date": "2018-05-30", "has_results": true, "last_update_posted_date": "2019-04-02", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03344510" }, { "nct_id": "NCT00864162", "title": "A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fed Conditions", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Ramipril10 mg Capsules, single dose", "type": "DRUG" }, { "name": "Atlace® 10 mg capsules, single dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Actavis Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 40, "start_date": "2004-09", "completion_date": "2004-10", "has_results": false, "last_update_posted_date": "2010-08-16", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00864162" }, { "nct_id": "NCT04310527", "title": "Bioavailability of Enasidenib (CC-90007) Sprinkle Formulation Relative to the Reference Tablet Formulation and Effect of Food on the Pharmacokinetics of Sprinkle Formulation in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "Enasidenib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 28, "start_date": "2019-10-09", "completion_date": "2019-12-09", "has_results": false, "last_update_posted_date": "2020-03-17", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04310527" }, { "nct_id": "NCT02187627", "title": "Evaluation of [11C]RO6924963, [11C]RO6931643, and [18F]RO6958948 as Tracers for Positron Emission Tomography (PET) Imaging of Tau in Healthy and Alzheimer's Disease (AD) Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alzheimer's Disease, Healthy Volunteer" ], "interventions": [ { "name": "[11C]RO6924963", "type": "DRUG" }, { "name": "[11C]RO6931643", "type": "DRUG" }, { "name": "[18F]RO6958948", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "25 Years", "maximum_age": null, "sex": "ALL", "summary": "25 Years and older" }, "enrollment_count": 52, "start_date": "2014-08-31", "completion_date": "2016-02-29", "has_results": false, "last_update_posted_date": "2019-01-02", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 2, "location_summary": "Baltimore, Maryland", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Baltimore", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT02187627" }, { "nct_id": "NCT00056420", "title": "Brain Dynamics Involved in Generating Tics and Controlling Voluntary Movement", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Tourette Syndrome", "Tic Disorders" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Neurological Disorders and Stroke (NINDS)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "21 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "21 Years to 65 Years" }, "enrollment_count": 54, "start_date": "2003-03-10", "completion_date": "2009-01-22", "has_results": false, "last_update_posted_date": "2017-07-02", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00056420" }, { "nct_id": "NCT05074459", "title": "A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Participants" ], "interventions": [ { "name": "Eptinezumab Mammalian Cell Line", "type": "DRUG" }, { "name": "Eptinezumab Yeast Cell Line", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "H. Lundbeck A/S", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 84, "start_date": "2021-09-27", "completion_date": "2022-07-18", "has_results": false, "last_update_posted_date": "2022-08-29", "last_synced_at": "2026-11-15T12:07:33.295Z", "location_count": 2, "location_summary": "Daytona Beach, Florida • Madison, Wisconsin", "locations": [ { "city": "Daytona Beach", "state": "Florida" }, { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05074459" } ] }